Software - Application
Compare Stocks
5 / 10Stock Comparison
EB vs ACMR vs LYV vs ICHR vs MKSI
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Entertainment
Semiconductors
Hardware, Equipment & Parts
EB vs ACMR vs LYV vs ICHR vs MKSI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Semiconductors | Entertainment | Semiconductors | Hardware, Equipment & Parts |
| Market Cap | $436M | $3.92B | $38.65B | $2.47B | $20.25B |
| Revenue (TTM) | $292M | $901M | $25.61B | $959M | $4.07B |
| Net Income (TTM) | $-11M | $94M | $84M | $-51M | $327M |
| Gross Margin | 67.6% | 44.4% | 40.3% | 11.3% | 45.2% |
| Operating Margin | -8.9% | 12.1% | 3.4% | -3.8% | 14.8% |
| Forward P/E | — | 29.7x | 115.8x | 62.2x | 30.4x |
| Total Debt | $145M | $303M | $12.44B | $186M | $4.69B |
| Cash & Equiv. | $300M | $766M | $7.11B | $98M | $675M |
EB vs ACMR vs LYV vs ICHR vs MKSI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Eventbrite, Inc. (EB) | 100 | 52.3 | -47.7% |
| ACM Research, Inc. (ACMR) | 100 | 279.4 | +179.4% |
| Live Nation Enterta… (LYV) | 100 | 329.8 | +229.8% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 209.0 | +109.0% |
| MKS Inc. (MKSI) | 100 | 231.4 | +131.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EB vs ACMR vs LYV vs ICHR vs MKSI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, EB doesn't own a clear edge in any measured category.
ACMR carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 30.7% 10Y total return vs MKSI's 7.5%
- Lower volatility, beta 3.24, Low D/E 15.7%, current ratio 3.27x
- 15.2% revenue growth vs EB's -10.2%
LYV is the #2 pick in this set and the best alternative if stability is your priority.
- Beta 0.80 vs ICHR's 3.93
ICHR ranks third and is worth considering specifically for momentum.
- +329.1% vs LYV's +24.0%
MKSI is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 0 yrs, beta 2.64, yield 0.3%
- Beta 2.64, yield 0.3%, current ratio 2.71x
- 0.3% yield, vs ACMR's 0.2%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.2% revenue growth vs EB's -10.2% | |
| Value | Lower P/E (29.7x vs 30.4x) | |
| Quality / Margins | 10.4% margin vs ICHR's -5.3% | |
| Stability / Safety | Beta 0.80 vs ICHR's 3.93 | |
| Dividends | 0.3% yield, vs ACMR's 0.2%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +329.1% vs LYV's +24.0% | |
| Efficiency (ROA) | 3.9% ROA vs ICHR's -5.2%, ROIC 7.0% vs -3.9% |
EB vs ACMR vs LYV vs ICHR vs MKSI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
EB vs ACMR vs LYV vs ICHR vs MKSI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACMR leads in 2 of 6 categories
MKSI leads 1 • EB leads 0 • LYV leads 0 • ICHR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MKSI leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LYV is the larger business by revenue, generating $25.6B annually — 87.8x EB's $292M. ACMR is the more profitable business, keeping 10.4% of every revenue dollar as net income compared to ICHR's -5.3%. On growth, MKSI holds the edge at +15.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $292M | $901M | $25.6B | $959M | $4.1B |
| EBITDAEarnings before interest/tax | -$26M | $126M | $1.6B | -$11M | $945M |
| Net IncomeAfter-tax profit | -$11M | $94M | $84M | -$51M | $327M |
| Free Cash FlowCash after capex | $13M | -$69M | $1.2B | -$17M | $401M |
| Gross MarginGross profit ÷ Revenue | +67.6% | +44.4% | +40.3% | +11.3% | +45.2% |
| Operating MarginEBIT ÷ Revenue | -8.9% | +12.1% | +3.4% | -3.8% | +14.8% |
| Net MarginNet income ÷ Revenue | -3.6% | +10.4% | +0.3% | -5.3% | +8.0% |
| FCF MarginFCF ÷ Revenue | +4.6% | -7.6% | +4.8% | -1.7% | +9.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.9% | +9.4% | +12.1% | +4.7% | +15.2% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.6% | -76.1% | -4.8% | +46.2% | +53.2% |
Valuation Metrics
Evenly matched — EB and ACMR and LYV each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, ACMR trades at a 37% valuation discount to MKSI's 68.8x P/E. On an enterprise value basis, LYV's 19.9x EV/EBITDA is more attractive than ACMR's 27.5x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $436M | $3.9B | $38.6B | $2.5B | $20.2B |
| Enterprise ValueMkt cap + debt − cash | $280M | $3.5B | $44.0B | $2.6B | $24.3B |
| Trailing P/EPrice ÷ TTM EPS | -41.00x | 43.21x | -692.98x | -46.25x | 68.83x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 115.80x | 62.25x | 30.36x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 27.49x | 19.89x | — | 26.70x |
| Price / SalesMarket cap ÷ Revenue | 1.49x | 4.35x | 1.53x | 2.61x | 5.15x |
| Price / BookPrice ÷ Book value/share | 2.43x | 2.06x | 21.20x | 3.67x | 7.49x |
| Price / FCFMarket cap ÷ FCF | 24.71x | — | 115.84x | — | 40.74x |
Profitability & Efficiency
ACMR leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MKSI delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-8 for ICHR. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to LYV's 6.84x. On the Piotroski fundamental quality scale (0–9), MKSI scores 6/9 vs ACMR's 2/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -5.9% | +6.1% | +4.4% | -7.5% | +12.2% |
| ROA (TTM)Return on assets | -1.4% | +3.9% | +0.4% | -5.2% | +3.7% |
| ROICReturn on invested capital | -187.3% | +7.0% | +19.7% | -3.9% | +6.5% |
| ROCEReturn on capital employed | -8.4% | +6.6% | +13.4% | -4.7% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 5 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.81x | 0.16x | 6.84x | 0.28x | 1.73x |
| Net DebtTotal debt minus cash | -$155M | -$463M | $5.3B | $87M | $4.0B |
| Cash & Equiv.Liquid assets | $300M | $766M | $7.1B | $98M | $675M |
| Total DebtShort + long-term debt | $145M | $303M | $12.4B | $186M | $4.7B |
| Interest CoverageEBIT ÷ Interest expense | — | 20.44x | 3.68x | -5.97x | 2.84x |
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $2,043 for EB. Over the past 12 months, ICHR leads with a +329.1% total return vs LYV's +24.0%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs EB's -11.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.6% | +31.9% | +14.5% | +249.0% | +78.8% |
| 1-Year ReturnPast 12 months | +106.9% | +195.6% | +24.0% | +329.1% | +306.1% |
| 3-Year ReturnCumulative with dividends | -30.3% | +487.9% | +113.7% | +151.1% | +266.0% |
| 5-Year ReturnCumulative with dividends | -79.6% | +133.4% | +108.0% | +28.9% | +66.5% |
| 10-Year ReturnCumulative with dividends | -87.6% | +3065.8% | +622.5% | +629.1% | +750.6% |
| CAGR (3Y)Annualised 3-year return | -11.3% | +80.5% | +28.8% | +35.9% | +54.1% |
Risk & Volatility
Evenly matched — EB and LYV each lead in 1 of 2 comparable metrics.
Risk & Volatility
LYV is the less volatile stock with a 0.80 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EB currently trades 100.0% from its 52-week high vs ACMR's 82.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.09x | 3.24x | 0.80x | 3.93x | 2.64x |
| 52-Week HighHighest price in past year | $4.51 | $71.65 | $175.25 | $72.87 | $326.83 |
| 52-Week LowLowest price in past year | $2.05 | $19.26 | $125.34 | $13.12 | $71.49 |
| % of 52W HighCurrent price vs 52-week peak | +100.0% | +82.6% | +94.9% | +97.7% | +92.0% |
| RSI (14)Momentum oscillator 0–100 | 60.8 | 60.7 | 63.6 | 66.9 | 65.3 |
| Avg Volume (50D)Average daily shares traded | 3.5M | 1.2M | 2.8M | 795K | 1.2M |
Analyst Outlook
Evenly matched — ACMR and MKSI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EB as "Hold", ACMR as "Buy", LYV as "Buy", ICHR as "Buy", MKSI as "Buy". Consensus price targets imply 149.0% upside for EB (target: $11) vs -32.4% for ACMR (target: $40). For income investors, MKSI offers the higher dividend yield at 0.29% vs ACMR's 0.19%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $11.23 | $40.00 | $181.00 | $49.80 | $272.86 |
| # AnalystsCovering analysts | 10 | 10 | 44 | 14 | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — | +0.3% |
| Dividend StreakConsecutive years of raises | — | 3 | 1 | 1 | 0 |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | +0.1% | 0.0% | +0.2% |
ACMR leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). MKSI leads in 1 (Income & Cash Flow). 3 tied.
EB vs ACMR vs LYV vs ICHR vs MKSI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EB or ACMR or LYV or ICHR or MKSI a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -10. 2% for Eventbrite, Inc. (EB). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EB or ACMR or LYV or ICHR or MKSI?
On trailing P/E, ACM Research, Inc.
(ACMR) is the cheapest at 43. 2x versus MKS Inc. at 68. 8x. On forward P/E, ACM Research, Inc. is actually cheaper at 29. 7x.
03Which is the better long-term investment — EB or ACMR or LYV or ICHR or MKSI?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -79. 6% for Eventbrite, Inc. (EB). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus EB's -87. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EB or ACMR or LYV or ICHR or MKSI?
By beta (market sensitivity over 5 years), Live Nation Entertainment, Inc.
(LYV) is the lower-risk stock at 0. 80β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately 394% more volatile than LYV relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 7% for Live Nation Entertainment, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EB or ACMR or LYV or ICHR or MKSI?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -10. 2% for Eventbrite, Inc. (EB). On earnings-per-share growth, the picture is similar: MKS Inc. grew EPS 55. 5% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EB or ACMR or LYV or ICHR or MKSI?
ACM Research, Inc.
(ACMR) is the more profitable company, earning 10. 4% net margin versus -5. 6% for Ichor Holdings, Ltd. — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MKSI leads at 14. 4% versus -8. 9% for EB. At the gross margin level — before operating expenses — EB leads at 67. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EB or ACMR or LYV or ICHR or MKSI more undervalued right now?
On forward earnings alone, ACM Research, Inc.
(ACMR) trades at 29. 7x forward P/E versus 115. 8x for Live Nation Entertainment, Inc. — 86. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EB: 149. 0% to $11. 23.
08Which pays a better dividend — EB or ACMR or LYV or ICHR or MKSI?
In this comparison, MKSI (0.
3% yield), ACMR (0. 2% yield) pay a dividend. EB, LYV, ICHR do not pay a meaningful dividend and should not be held primarily for income.
09Is EB or ACMR or LYV or ICHR or MKSI better for a retirement portfolio?
For long-horizon retirement investors, Live Nation Entertainment, Inc.
(LYV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 80), +622. 5% 10Y return). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LYV: +622. 5%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EB and ACMR and LYV and ICHR and MKSI?
These companies operate in different sectors (EB (Technology) and ACMR (Technology) and LYV (Communication Services) and ICHR (Technology) and MKSI (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EB is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; LYV is a mid-cap quality compounder stock; ICHR is a small-cap quality compounder stock; MKSI is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 6%
- Gross Margin > 24%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.